187 related articles for article (PubMed ID: 25319577)
1. LINE-1 methylation level and patient prognosis in a database of 208 hepatocellular carcinomas.
Harada K; Baba Y; Ishimoto T; Chikamoto A; Kosumi K; Hayashi H; Nitta H; Hashimoto D; Beppu T; Baba H
Ann Surg Oncol; 2015 Apr; 22(4):1280-7. PubMed ID: 25319577
[TBL] [Abstract][Full Text] [Related]
2. Expression analysis of THOP1 in background liver, a prognostic predictive factor in hepatocellular carcinoma, extracted by multiarray analysis.
Nomoto S; Hishida M; Inokawa Y; Takano N; Kanda M; Nishikawa Y; Fujii T; Koike M; Sugimoto H; Kodera Y
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S443-50. PubMed ID: 24604581
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of the stem cell marker CD133 associated with Line-1 demethylation in hepatocellular carcinoma.
Zhang C; Xu Y; Zhao J; Fan L; Jiang G; Li R; Ling Y; Wu M; Wei L
Ann Surg Oncol; 2011 Aug; 18(8):2373-80. PubMed ID: 21331808
[TBL] [Abstract][Full Text] [Related]
4. LINE-1 hypomethylation is associated with a poor prognosis among patients with curatively resected esophageal squamous cell carcinoma.
Iwagami S; Baba Y; Watanabe M; Shigaki H; Miyake K; Ishimoto T; Iwatsuki M; Sakamaki K; Ohashi Y; Baba H
Ann Surg; 2013 Mar; 257(3):449-55. PubMed ID: 23023202
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of serum LINE-1 hypomethylation as a prognostic marker for hepatocellular carcinoma.
Ramzy II; Omran DA; Hamad O; Shaker O; Abboud A
Arab J Gastroenterol; 2011 Sep; 12(3):139-42. PubMed ID: 22055592
[TBL] [Abstract][Full Text] [Related]
6. Expressions of hypoxia-inducible factor-1 and epithelial cell adhesion molecule are linked with aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy.
Yamada S; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y; Takasu C; Ishikawa D; Shimada M
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S436-42. PubMed ID: 24566861
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation profiling identifies EYA4 gene as a prognostic molecular marker in hepatocellular carcinoma.
Hou X; Peng JX; Hao XY; Cai JP; Liang LJ; Zhai JM; Zhang KS; Lai JM; Yin XY
Ann Surg Oncol; 2014 Nov; 21(12):3891-9. PubMed ID: 24306662
[TBL] [Abstract][Full Text] [Related]
8. CpG island methylator phenotype associated with tumor recurrence in tumor-node-metastasis stage I hepatocellular carcinoma.
Li B; Liu W; Wang L; Li M; Wang J; Huang L; Huang P; Yuan Y
Ann Surg Oncol; 2010 Jul; 17(7):1917-26. PubMed ID: 20112070
[TBL] [Abstract][Full Text] [Related]
9. LINE-1 hypomethylation, DNA copy number alterations, and CDK6 amplification in esophageal squamous cell carcinoma.
Baba Y; Watanabe M; Murata A; Shigaki H; Miyake K; Ishimoto T; Iwatsuki M; Iwagami S; Yoshida N; Oki E; Sakamaki K; Nakao M; Baba H
Clin Cancer Res; 2014 Mar; 20(5):1114-24. PubMed ID: 24423610
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation.
Zhang F; Wu LM; Zhou L; Chen QX; Xie HY; Feng XW; Zheng SS
Ann Surg Oncol; 2008 Dec; 15(12):3494-502. PubMed ID: 18830757
[TBL] [Abstract][Full Text] [Related]
11. Decreased PADI4 mRNA association with global hypomethylation in hepatocellular carcinoma during HBV exposure.
Zhang C; Fan L; Fan T; Wu D; Gao L; Ling Y; Zhu J; Li R; Wei L
Cell Biochem Biophys; 2013 Mar; 65(2):187-95. PubMed ID: 22907585
[TBL] [Abstract][Full Text] [Related]
12. LINE-1 hypomethylation in gastric cancer, detected by bisulfite pyrosequencing, is associated with poor prognosis.
Shigaki H; Baba Y; Watanabe M; Murata A; Iwagami S; Miyake K; Ishimoto T; Iwatsuki M; Baba H
Gastric Cancer; 2013 Oct; 16(4):480-7. PubMed ID: 23179365
[TBL] [Abstract][Full Text] [Related]
13. Hypomethylation of long interspersed nuclear element-1 promoter is associated with poor outcomes for curative resected hepatocellular carcinoma.
Gao XD; Qu JH; Chang XJ; Lu YY; Bai WL; Wang H; Xu ZX; An LJ; Wang CP; Zeng Z; Yang YP
Liver Int; 2014 Jan; 34(1):136-46. PubMed ID: 23875825
[TBL] [Abstract][Full Text] [Related]
14. Pyrosequencing assay to measure LINE-1 methylation level in esophageal squamous cell carcinoma.
Iwagami S; Baba Y; Watanabe M; Shigaki H; Miyake K; Ida S; Nagai Y; Ishimoto T; Iwatsuki M; Sakamoto Y; Miyamoto Y; Baba H
Ann Surg Oncol; 2012 Aug; 19(8):2726-32. PubMed ID: 22187122
[TBL] [Abstract][Full Text] [Related]
15. Aberrant methylation of the CADM1 promoter is associated with poor prognosis in hepatocellular carcinoma treated with liver transplantation.
Zhang W; Zhou L; Ding SM; Xie HY; Xu X; Wu J; Chen QX; Zhang F; Wei BJ; Eldin AT; Zheng SS
Oncol Rep; 2011 Apr; 25(4):1053-62. PubMed ID: 21271221
[TBL] [Abstract][Full Text] [Related]
16. A survey of c-MET expression and amplification in 287 patients with hepatocellular carcinoma.
Lee SJ; Lee J; Sohn I; Mao M; Kai W; Park CK; Lim HY
Anticancer Res; 2013 Nov; 33(11):5179-86. PubMed ID: 24222167
[TBL] [Abstract][Full Text] [Related]
17. LINE-1 hypomethylation in noncancerous esophageal mucosae is associated with smoking history.
Shigaki H; Baba Y; Watanabe M; Iwagami S; Miyake K; Ishimoto T; Iwatsuki M; Baba H
Ann Surg Oncol; 2012 Dec; 19(13):4238-43. PubMed ID: 22766991
[TBL] [Abstract][Full Text] [Related]
18. Altered methionine metabolism and global DNA methylation in liver cancer: relationship with genomic instability and prognosis.
Calvisi DF; Simile MM; Ladu S; Pellegrino R; De Murtas V; Pinna F; Tomasi ML; Frau M; Virdis P; De Miglio MR; Muroni MR; Pascale RM; Feo F
Int J Cancer; 2007 Dec; 121(11):2410-20. PubMed ID: 17680562
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide hypomethylation in hepatocellular carcinogenesis.
Lin CH; Hsieh SY; Sheen IS; Lee WC; Chen TC; Shyu WC; Liaw YF
Cancer Res; 2001 May; 61(10):4238-43. PubMed ID: 11358850
[TBL] [Abstract][Full Text] [Related]
20. Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma.
Chiba T; Saito T; Yuki K; Zen Y; Koide S; Kanogawa N; Motoyama T; Ogasawara S; Suzuki E; Ooka Y; Tawada A; Otsuka M; Miyazaki M; Iwama A; Yokosuka O
Int J Cancer; 2015 Jan; 136(2):289-98. PubMed ID: 24844570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
